Home » Healthcare » India Single-Use Bio-Processing Systems Market

India Single-Use Bio-Processing Systems Market

India Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Contract Manufacturing Organizations (CMOs), Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
India Single-Use Bio-Processing Systems Market Size 2024	USD 508.91 million
India Single-Use Bio-Processing Systems Market, CGR	18.48%
India Single-Use Bio-Processing Systems Market Size 2032	USD 1,975.68 million

Market Overview

India Single-Use Bio-Processing Systems market size was valued at USD 508.91 million in 2024 and is anticipated to reach USD 1,975.68 million by 2032, at a CAGR of 18.48% during the forecast period (2024-2032).

The India Single-Use Bio-Processing Systems market is driven by the rising demand for biopharmaceutical production and advancements in biotechnology. These systems offer significant advantages, including reduced contamination risks, cost-efficiency, and flexibility in manufacturing processes, making them highly attractive to biopharma companies. The growing trend toward personalized medicine and cell-based therapies is further accelerating the adoption of single-use systems, as they enable scalable and adaptable production methods. Additionally, the increasing focus on minimizing capital expenditure and operational costs in biomanufacturing has led to the widespread preference for single-use technologies. Government initiatives supporting the biotechnology sector, coupled with favorable regulatory frameworks, are also contributing to market growth. These trends are expected to continue driving the market expansion as manufacturers look for innovative, sustainable, and efficient solutions to meet the rising demand for biologics and vaccines in India.

Geographically, the India Single-Use Bio-Processing Systems market is predominantly concentrated in regions like Northern, Western, Southern, and Eastern India, each contributing significantly to the overall market growth. The Northern and Western regions, particularly around Delhi, Mumbai, and Gujarat, are major hubs for pharmaceutical and biotechnology companies, driving the adoption of single-use systems in biomanufacturing. The Southern region, with key cities like Bengaluru and Hyderabad, has emerged as a biotech hotspot, further boosting market expansion. Leading players in the Indian market include global and regional companies like Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, Merck Life Science, and Thermo Fisher Scientific. These companies are instrumental in advancing the adoption of single-use technologies by offering a wide range of products and services to meet the growing demand for biopharmaceutical production. Their continued innovation and strategic expansions in India further support the market’s robust growth.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The India Single-Use Bio-Processing Systems market was valued at USD 508.91 million in 2024 and is projected to reach USD 1,975.68 million by 2032, growing at a CAGR of 18.48% during the forecast period.

The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.

The increasing demand for biopharmaceuticals and the shift toward personalized medicine are driving market growth.
Technological advancements in biotechnology and the rising preference for cost-effective, scalable production solutions are key market trends.
Competitive players include Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, and Merck Life Science, with a focus on innovation and expanding product portfolios.
Market restraints include the high cost of single-use components and the lack of standardized regulatory guidelines.
Regional growth is concentrated in the Northern and Western regions, driven by major pharmaceutical hubs in cities like Delhi and Mumbai.
Southern India’s biotech growth and increasing government support are fueling market expansion in this region.

Report Scope

This report segments the India Single-Use Bio-Processing Systems Market as follows:

Market Drivers

Growing Demand for Biopharmaceuticals

One of the primary drivers behind the rapid growth of the India Single-Use Bio-Processing Systems market is the increasing demand for biopharmaceuticals. As the global healthcare landscape evolves, there has been a significant rise in the production of biologics, vaccines, and monoclonal antibodies. For instance, the Central Drugs Standard Control Organization (CDSCO) has emphasized the importance of single-use technologies in ensuring sterility and efficiency in biopharmaceutical production. The demand for these therapies has accelerated in recent years due to the need for more targeted and personalized treatment options for various chronic diseases and conditions such as cancer, autoimmune disorders, and infectious diseases. Single-use bio-processing systems provide a flexible, cost-effective, and scalable solution to meet these production requirements, making them essential for manufacturers striving to fulfill the growing demand for biopharmaceuticals in India.

Technological Advancements in Biotechnology

Advancements in biotechnology and biomanufacturing technologies have been a major catalyst for the adoption of single-use systems in India. For instance, the Department of Biotechnology, Government of India, has launched a policy framework to accelerate biomanufacturing innovations, including single-use technologies. Innovations such as continuous bioprocessing, improved cell culture technologies, and automation have enhanced the efficiency and reliability of bio-manufacturing processes. These innovations allow manufacturers to produce higher-quality products in shorter timeframes, reducing overall production costs. Furthermore, as the biotechnology sector in India expands and matures, there is a growing emphasis on adopting cutting-edge technologies to stay competitive. Single-use bio-processing systems align perfectly with these advancements, offering superior flexibility and adaptability in a rapidly evolving industry.

Cost-Efficiency and Operational Flexibility

Cost-efficiency is a significant factor driving the adoption of single-use bio-processing systems in India. Traditional bioprocessing systems often require costly investments in equipment, maintenance, and cleaning, as well as long downtime for sterilization. Single-use systems, by contrast, are more cost-effective, as they eliminate the need for cleaning and sterilization between batches, thus reducing downtime and operational costs. Additionally, single-use systems require minimal capital investment in infrastructure and can be quickly deployed for small or large-scale production runs. This operational flexibility is particularly beneficial for contract manufacturing organizations (CMOs) and small-to-medium-sized enterprises (SMEs) that need to scale production efficiently without heavy upfront costs.

Regulatory Support and Industry Initiatives

The Indian government’s increasing support for the biotechnology and pharmaceutical sectors is another key driver of the market. Government policies and initiatives aimed at strengthening the country’s biomanufacturing capabilities and promoting the growth of the life sciences industry have created a favorable environment for the adoption of advanced manufacturing technologies, including single-use systems. Regulatory bodies in India have also streamlined their approval processes for new biologics and biosimilars, which has further stimulated the growth of biopharmaceutical production. These favorable regulations, along with tax incentives and infrastructure development initiatives, contribute to the growing demand for single-use bio-processing systems as companies seek to meet regulatory requirements and gain a competitive edge in the market.

Market Trends

Increasing Adoption of Personalized Medicine

A prominent trend driving the India Single-Use Bio-Processing Systems market is the growing focus on personalized medicine. As medical treatments become more individualized, there is an increasing need for scalable, flexible, and efficient manufacturing solutions. Single-use bio-processing systems are particularly well-suited to meet the demands of personalized medicine, which often requires small-batch production for targeted therapies. These systems allow for rapid changeover between different products, enhancing their suitability for personalized approaches in drug development. With biopharmaceutical companies investing more in precision medicine, the adoption of single-use systems is expected to rise, as they offer the flexibility to produce small quantities of specialized treatments without the extensive infrastructure of traditional stainless-steel systems.

Shift Towards Continuous Bioprocessing

The industry is increasingly shifting towards continuous bioprocessing as a means of improving efficiency and scalability in biologics production. This trend is being fueled by the ability of continuous processing to enhance yield, reduce manufacturing costs, and increase overall productivity. For instance, the India Continuous Bioprocessing Market report highlights that continuous bioprocessing is expected to grow significantly due to its ability to improve efficiency and reduce costs. Single-use bio-processing systems are key enablers of this shift, as they provide the required flexibility and ease of integration for continuous manufacturing lines. Unlike traditional batch processing, continuous bioprocessing allows for the constant production of biologics, ensuring a steady supply of products. As the benefits of continuous bioprocessing become more evident, companies in India are adopting single-use systems to support this transition, thereby contributing to market growth.

Sustainability and Environmental Considerations

Sustainability is an increasingly important trend in the biomanufacturing sector, and single-use bio-processing systems align well with environmental goals. Traditional bioprocessing systems often require significant amounts of water and energy for cleaning and sterilization, leading to higher resource consumption and environmental impact. For instance, the Bio-Process Systems Alliance (BPSA) has released a report highlighting how single-use technologies reduce water, chemical, and energy usage, minimizing environmental impact. In contrast, single-use systems eliminate the need for cleaning and sterilization, reducing waste and energy consumption. As the Indian biopharmaceutical industry seeks to improve its environmental footprint and meet sustainability goals, the shift towards single-use systems is expected to accelerate. Additionally, advancements in biodegradable and recyclable materials used in these systems further support the growing trend toward environmentally conscious manufacturing practices.

Expansion of Contract Manufacturing Organizations (CMOs)

The rise of Contract Manufacturing Organizations (CMOs) in India is another key trend influencing the market. As the demand for biopharmaceuticals grows, many companies are opting to outsource their manufacturing needs to CMOs, which offer specialized services and expertise in bioprocessing. Single-use bio-processing systems are an attractive solution for CMOs due to their cost-effectiveness, scalability, and minimal infrastructure requirements. CMOs can rapidly adjust to changing customer demands and optimize production processes using these systems, making them a preferred choice for outsourced biomanufacturing. As the CMO market expands in India, the demand for single-use systems is expected to grow, driven by the need for flexible and efficient manufacturing solutions.

Market Challenges Analysis

High Cost of Single-Use Components

One of the primary challenges facing the India Single-Use Bio-Processing Systems market is the relatively high cost of single-use components, such as bioreactors, filters, and disposable bags. While these systems offer significant operational savings through reduced maintenance and cleaning costs, the initial purchase and ongoing supply of single-use components can be expensive. For smaller biopharmaceutical companies and contract manufacturers operating on tight budgets, the upfront cost of adopting single-use technologies can be a barrier. Additionally, the long-term reliance on disposable components increases the total cost of ownership, which may deter companies from transitioning to single-use systems, particularly in a price-sensitive market like India. The high cost of raw materials used in these systems, coupled with fluctuating market prices, further exacerbates the financial strain on manufacturers.

Regulatory and Standardization Challenges

Another significant challenge in the Indian market is the lack of consistent regulatory guidelines and standards for single-use bio-processing systems. While India has made strides in creating favorable regulations for biomanufacturing, there is still a lack of clear, standardized protocols specifically addressing the use of single-use systems. For instance, the Department of Biotechnology, Government of India, is preparing to launch a new policy framework to streamline biomanufacturing regulations, including single-use technologies. This creates uncertainty for manufacturers, particularly those wishing to enter the market or expand operations. Regulatory bodies may have varying requirements regarding product approvals, safety standards, and validation processes for single-use systems, which can complicate the adoption and scaling of these technologies. Furthermore, the absence of a harmonized global framework for single-use system validation may lead to delays in product commercialization and higher costs for manufacturers, as they must navigate complex and often fragmented regulatory environments.

Market Opportunities

The India Single-Use Bio-Processing Systems market presents significant opportunities driven by the country’s rapidly growing biopharmaceutical sector. As the demand for biologics, vaccines, and personalized medicine continues to rise, there is an increasing need for efficient, scalable, and cost-effective manufacturing solutions. Single-use systems offer flexibility and speed in production, enabling biomanufacturers to meet the growing demand without the need for significant infrastructure investments. This creates a substantial opportunity for both established biopharma companies and emerging startups to adopt single-use technologies to optimize their production processes. Additionally, with the Indian government actively promoting the biotechnology sector through favorable policies, tax incentives, and infrastructure development, the market is well-positioned for growth, making it an attractive space for investment and innovation.

Furthermore, the expanding presence of Contract Manufacturing Organizations (CMOs) in India offers a promising opportunity for single-use bio-processing systems. As CMOs continue to gain prominence, particularly in serving global biopharmaceutical companies, the demand for flexible, efficient, and cost-effective manufacturing solutions grows. Single-use systems are well-suited for contract manufacturers due to their ability to quickly adapt to different product requirements, scale production efficiently, and minimize costs. This trend is further fueled by the increasing preference for outsourcing in the biopharmaceutical industry. As India becomes a key hub for global pharmaceutical and biotechnology manufacturing, there is considerable potential for single-use systems to gain market share, allowing manufacturers to remain competitive while meeting regulatory requirements and international standards.

Market Segmentation Analysis:

By Type:

The India Single-Use Bio-Processing Systems market is primarily segmented by type into Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, and others. Among these, Single-Use Bioreactors hold the largest market share due to their crucial role in cell culture and fermentation processes in biologics production. These bioreactors provide flexibility, reduce contamination risks, and offer scalable solutions, which are essential for the efficient production of therapeutic proteins and vaccines. Single-Use Mixers are also gaining traction, particularly in upstream processing, where they aid in mixing cultures and media efficiently without the need for cleaning or sterilization. Single-Use Bags, used for storage, transportation, and media preparation, are increasingly popular due to their cost-effectiveness and convenience. Single-Use Connectors facilitate the sterile transfer of liquids and gases in bioprocessing, which is essential for maintaining process integrity. Other components, such as filters and sensors, contribute to the overall performance of single-use systems, further driving their adoption across biopharma manufacturing.

By Application:

In terms of application, the market is segmented into Research & Development, Manufacturing, Process Development, Commercial Production, and others. Manufacturing and Commercial Production are the largest segments, driven by the growing demand for biopharmaceutical products. Single-use bio-processing systems offer manufacturers a cost-effective and scalable solution to meet the rising demand for biologics, particularly in monoclonal antibody and vaccine production. Process Development is another key segment, where these systems are used to optimize production processes, conduct feasibility studies, and ensure product consistency. In Research & Development, single-use systems provide flexibility for small-scale production runs, accelerating the development of new biologic drugs and therapies. These systems also play a significant role in Commercial Production, enabling efficient, high-quality large-scale manufacturing while maintaining compliance with stringent regulatory standards. The increasing adoption of single-use technologies in both small and large-scale applications is expected to further boost market growth in India.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

Northern
Western
Southern
Eastern

Regional Analysis

Northern region

The Northern region of India holds a significant share of the market for Single-Use Bio-Processing Systems, contributing approximately 35% to the overall market. This region benefits from the presence of major pharmaceutical and biotechnology hubs, particularly in states like Delhi, Haryana, and Punjab. The region’s well-established infrastructure, coupled with the presence of large-scale manufacturing units, drives the adoption of advanced biomanufacturing technologies, including single-use systems. Additionally, the northern region hosts numerous research institutions and universities that contribute to the development and commercialization of biopharmaceuticals. The growing investment in biotech startups and contract manufacturing organizations (CMOs) in the region further supports market growth.

Western region

The Western region follows closely, accounting for about 30% of the market share. This region, encompassing Maharashtra, Gujarat, and Rajasthan, is home to some of the largest pharmaceutical and biotech companies in India, including global giants in the biopharmaceutical industry. Mumbai, in particular, is a major commercial and manufacturing hub, driving demand for efficient, scalable production solutions such as single-use bio-processing systems. The Western region’s strong focus on innovation and research, along with its favorable regulatory environment, has led to rapid adoption of advanced technologies in biomanufacturing, bolstering the growth of the single-use systems market.

Southern region

In the Southern region, comprising states like Karnataka, Tamil Nadu, and Andhra Pradesh, the market share for single-use bio-processing systems is approximately 25%. Southern India has become a key player in the biopharmaceutical sector due to its burgeoning biotechnology industry, particularly in Bengaluru and Hyderabad, which are emerging biotech hubs. The presence of leading pharmaceutical companies and contract research organizations (CROs) in this region promotes the adoption of cutting-edge manufacturing technologies, including single-use systems. The region’s emphasis on innovation, coupled with increasing government support for biotech initiatives, creates a favorable environment for the market to expand.

Eastern region

The Eastern region, including states like West Bengal, Odisha, and Bihar, currently holds around 10% of the market share. While this region lags behind in terms of overall market size, it is experiencing growth driven by the expansion of pharmaceutical manufacturing and increasing investments in biotechnology. The region’s relatively lower adoption of advanced bioprocessing technologies presents significant growth potential as local manufacturers begin to explore more efficient and cost-effective solutions like single-use bio-processing systems. The government’s initiatives to strengthen the biopharmaceutical sector in this region, coupled with the rise of biotech startups, are expected to foster the expansion of the market in the coming years.

Key Player Analysis

Wuxi AppTec
Shanghai Bailun Biotechnology Co., Ltd.
Tsinghua University Suzhou Institute for Biomedicine
FUJIFILM Irvine Scientific
Cytiva
Hitachi Chemical Co., Ltd.
Mitsubishi Gas Chemical Company, Inc.
Merck Life Science
Thermo Fisher Scientific Asia
Danaher Asia-Pacific

Competitive Analysis

The India Single-Use Bio-Processing Systems market is highly competitive, with several global and regional players leading the industry. Key players such as Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, Merck Life Science, Thermo Fisher Scientific, Shanghai Bailun Biotechnology Co., Ltd., Tsinghua University Suzhou Institute for Biomedicine, Hitachi Chemical Co., Ltd., Mitsubishi Gas Chemical Company, Inc., and Danaher Asia-Pacific are at the forefront of driving innovation and market growth. These companies offer a wide range of single-use products, including bioreactors, mixers, bags, and connectors, catering to the diverse needs of biopharmaceutical manufacturers. Competitive strategies include enhancing product portfolios with advanced features such as automation, digitalization, and integration with existing biomanufacturing systems to improve efficiency and reduce production costs. Moreover, market players are emphasizing strong R&D capabilities to introduce more flexible and adaptable single-use systems to cater to diverse biopharmaceutical needs, such as personalized medicine and small-scale production runs. Partnerships and collaborations with biopharma companies, universities, and contract manufacturers are common strategies to expand market reach and gain access to emerging markets. As the biopharmaceutical industry continues to grow, competition is expected to intensify, with key players focusing on technological advancements, sustainability, and regional expansion. This will likely lead to the continued adoption of single-use systems, particularly in fast-growing regions such as Southern and Western India, which have become key hubs for biopharma manufacturing.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The India Single-Use Bio-Processing Systems market exhibits moderate concentration, with a mix of both global and regional players competing for market share. The market is characterized by the presence of several large multinational companies offering a diverse range of single-use products, including bioreactors, mixers, and connectors, alongside local players focused on cost-effective and scalable solutions. This competitive landscape drives innovation, with companies investing heavily in research and development to offer more flexible, efficient, and automated solutions. The market’s characteristics also include a strong focus on regulatory compliance and quality standards, as biopharmaceutical manufacturers seek to meet stringent guidelines for biologics production. The growth of contract manufacturing organizations (CMOs) and increasing demand from small-to-medium-sized enterprises further contribute to market fragmentation, with a rising number of players entering the market to cater to the expanding needs of the biopharma sector. This dynamic environment fosters continuous advancements in single-use bio-processing technologies.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for single-use bio-processing systems in India is expected to continue growing due to the increasing production of biologics and vaccines.
Advancements in biotechnology and automation will drive further adoption of single-use systems, improving efficiency and scalability.
Personalized medicine will fuel the need for flexible, small-scale production solutions offered by single-use systems.
The rise of contract manufacturing organizations (CMOs) in India will create additional demand for cost-effective and scalable bio-processing solutions.
Environmental concerns will lead to more sustainable and biodegradable materials being used in single-use systems, reducing waste and improving eco-friendliness.
Continued government support for the biotechnology sector will encourage the expansion of biomanufacturing capabilities and the adoption of single-use technologies.
Regulatory frameworks for single-use systems in India will become more standardized, providing clearer guidelines for manufacturers and ensuring smoother adoption.
The increasing preference for continuous bioprocessing over traditional batch processes will drive the demand for single-use technologies.
Small and medium-sized enterprises (SMEs) in the biopharma sector will increasingly adopt single-use systems to reduce capital investment and enhance operational flexibility.
The market will see more strategic collaborations between biopharma companies and equipment manufacturers to develop customized single-use solutions tailored to specific production needs.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. India Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by India 31

5.1.1. India Single-Use Bio-Processing Systems Market Import Volume/Revenue, By India, 2018 – 2023 31

5.2. Export Analysis by India 32

5.2.1. India Single-Use Bio-Processing Systems Market Export Volume/Revenue, By India, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by India 33

6.1.1. India Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By India, 2018 – 2023 33

6.2. Supply Analysis by India 34

6.2.1. India Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By India, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by India 35

7.1.1. India Single-Use Bio-Processing Systems Market Production Volume/Revenue, By India, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. India Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. India Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. India Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. India Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. India Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. India Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. India Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. India Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

India Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDIA ANALYSIS 76

16.1. Type 76

16.1.1. India Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. India Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. India Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. India Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. India Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. India Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Wuxi AppTec 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Shanghai Bailun Biotechnology Co., Ltd. 81

17.3. Tsinghua University Suzhou Institute for Biomedicine 81

17.4. FUJIFILM Irvine Scientific 81

17.5. Cytiva 81

17.6. Hitachi Chemical Co., Ltd. 81

17.7. Mitsubishi Gas Chemical Company, Inc. 81

17.8. Merck Life Science 81

17.9. Thermo Fisher Scientific Asia 81

17.10. Danaher Asia-Pacific 81

List of Figures

FIG NO. 1. India Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for India Single-Use Bio-Processing Systems Market 29

FIG NO. 3. India Single-Use Bio-Processing Systems Market Import Volume/Revenue, By India, 2018 – 2023 31

FIG NO. 4. India Single-Use Bio-Processing Systems Market Export Volume/Revenue, By India, 2018 – 2023 32

FIG NO. 5. India Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By India, 2018 – 2023 33

FIG NO. 6. India Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By India, 2018 – 2023 34

FIG NO. 7. India Single-Use Bio-Processing Systems Market Production Volume/Revenue, By India, 2018 – 2023 35

FIG NO. 8. India Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for India Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. India Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. India Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. India Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. India Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. India Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. India Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. India Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. India Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. India Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. India Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. India Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. India Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. India Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. India Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. India Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : India Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : India Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : India Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : India Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : India Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : India Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : India Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : India Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the India Single-Use Bio-Processing Systems?

The market was valued at USD 508.91 million in 2024 and is projected to reach USD 1,975.68 million by 2032.

What factors are driving the growth of the India Single-Use Bio-Processing Systems?

Rising demand for biopharmaceuticals, personalized medicine, cost-efficiency, and government support are key drivers.

What are some challenges faced by the India Single-Use Bio-Processing Systems?

High costs of components and lack of standardized regulatory guidelines hinder widespread adoption.

Who are the major players in the India Single-Use Bio-Processing Systems?

Key players include Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, Merck Life Science, and Thermo Fisher Scientific.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –